Racial disparities are historically profound and affect outcomes in early stage non–small-cell lung cancer. We aimed to explore if recent advances in radiotherapy and surgery have improved epidemiological differences in outcomes related to race. African American patients continued to do worse in a contemporary Surveillance, Epidemiology, and End Results data set, because of increased association with T2 disease, older age, squamous histology, male sex, and suboptimal treatment.
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine
- Cancer Research